Estimaciones de analistas de Wall Street para Elutia Inc (ELUT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 5 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 5 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.15 | ||
| 2026-08-13 | $-0.17 | $-0.15 | -13.3% |
| 2026-05-14 | $-0.17 | $-0.15 | -13.3% |
| 2026-03-11 | $-0.14 | $-0.14 | +0.0% |
| 2025-11-06 | $-0.01 | $-0.15 | +93.5% |
| 2025-08-14 | $-0.26 | $-0.17 | -52.9% |
| 2025-05-08 | $-0.21 | $-0.20 | -5.0% |
| 2025-03-06 | $-0.26 | $-0.25 | -4.0% |
Ratios de valoración
| Ratio P/E | 0.60 |
| Precio / Valor contable | 2.18 |
| EV / EBITDA | -1.13 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $39.0M | $42.9M | $42.7M | $47.4M | $23.8M | $24.7M | $24.4M | $12.3M |
| Coste de Ventas | $23.1M | $23.1M | $22.1M | $28.4M | $12.2M | $13.7M | $13.7M | $5.7M |
| Beneficio Bruto | $15.9M | $19.8M | $20.6M | $19.0M | $11.6M | $11.1M | $10.7M | $6.6M |
| I+D | $2.5M | $2.4M | $6.0M | $9.3M | $7.7M | $4.4M | $3.8M | $4.2M |
| Generales y Administrativos | $21.7M | $25.8M | $28.2M | $32.5M | $33.9M | $27.2M | $31.2M | $20.8M |
| Gastos Operativos | $24.2M | $28.2M | $34.2M | $42.1M | $46.8M | $41.6M | $46.4M | $25.0M |
| Beneficio Operativo | -$8.2M | -$8.4M | -$13.6M | -$23.0M | -$35.2M | -$30.5M | -$35.7M | -$18.4M |
| EBITDA | -$2.2M | -$2.7M | -$12.3M | -$15.7M | -$27.3M | -$31.9M | -$45.9M | -$13.5M |
| Gastos por Intereses | $5.5M | $5.4M | $5.6M | $5.3M | $5.1M | $5.8M | $4.8M | -$387000 |
| Beneficio Antes de Impuestos | -$11.5M | -$11.9M | -$21.8M | -$24.8M | -$36.1M | -$41.2M | -$54.1M | -$15.9M |
| Impuestos | $26000 | $30000 | $26000 | $55000 | $34000 | $28000 | $7000 | $13000 |
| Beneficio Neto | -$11.6M | -$11.9M | -$21.8M | -$24.8M | -$32.9M | -$37.7M | -$53.9M | $53.4M |
| BPA | $-1.08 | $-1.12 | $-2.13 | $-2.38 | $-2.38 | $-2.07 | $-1.86 | $1.29 |
| BPA Diluido | $-1.08 | $-1.12 | $-2.13 | $-2.38 | $-2.38 | $-2.07 | $-1.86 | $0.87 |
| Acciones en Circulación (Diluidas) | $10.7M | $10.7M | $10.2M | $10.4M | $13.8M | $18.2M | $29.1M | $45.9M |
Precio
| Precio | $0.81 |
| Capitalización | $36M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANVS · BCAB · CALC · CELU · LTRN · MAIA · PYPD
Explorar sector: Healthcare · Biotechnology
Más secciones de ELUT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones